18th Jan 2022 15:42
SkinBioTherapeutics PLC - Macclesfield, England-based life science company focused on skin health - Says has started process to recruit a full-time chief financial officer by early in the second quarter. Doug Quinn has acted as part-time CFO since SkinBioTherapeutics' listing on AIM in 2017, but the company thinks a new full-time CFO is required, working from its Newcastle upon Tyne office. SkinBioTherapeutics said it also is looking to recruit a new non-executive director.
Current stock price: 34.20 pence, down 4.3% on Tuesday
12-month change: up 16%
By Tom Waite; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Skinbiotherap.